These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12064931)

  • 1. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural correlation between collagen VI microfibrils and collagen VI banded aggregates.
    Knupp C; Pinali C; Munro PM; Gruber HE; Sherratt MJ; Baldock C; Squire JM
    J Struct Biol; 2006 Jun; 154(3):312-26. PubMed ID: 16713302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
    Majid MA; Smith VA; Newby AC; Dick AD
    Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprint of "Structural correlation between collagen VI microfibrils and collagen VI banded aggregates" [J. Struct. Biol. 154 (2006) 312-326].
    Knupp C; Pinali C; Munro PM; Gruber HE; Sherratt MJ; Baldock C; Squire JM
    J Struct Biol; 2006 Aug; 155(2):379-93. PubMed ID: 16934714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen VI assemblies in age-related macular degeneration.
    Knupp C; Amin SZ; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002 Sep; 139(3):181-9. PubMed ID: 12457848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of abnormal molecular assemblies (collagen VI) associated with human full thickness macular holes.
    Knupp C; Munro PM; Luther PK; Ezra E; Squire JM
    J Struct Biol; 2000 Feb; 129(1):38-47. PubMed ID: 10675295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
    Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
    Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
    Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of TIMP-3 expression and Bruch's membrane thickness in human macula.
    Bailey TA; Alexander RA; Dubovy SR; Luthert PJ; Chong NH
    Exp Eye Res; 2001 Dec; 73(6):851-8. PubMed ID: 11846515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
    Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
    Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
    Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
    Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
    Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
    J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
    Gourier HC; Chong NV
    J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
    Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.